1 . Weight 2 . BP 3 . Heart rate

96 ADV Pharm | TextBook | StudyGuide 4 . Serum Glucose 17. Evidence is strong that the timing of HF interventions are best initiated when: 1 . The person enters stage C 2 . The person has functional disabilities 3 . At the earliest indication 4 . When stage IV is determined 18. HF patients frequently take more than one drug. When are anticoagulants typically used? 1 . When the patient enters stage III 2 . Only in cases of diastolic failure 3 . When there is concurrent A Fib 4 . In all cases 19. What can chest x-rays contribute to the diagnosis & management of HF? 1 . They have no role. 2 . They can give very precise pictures of pulmonary fluid status. 3 . They provide an idea of general cardiac size & pulmonary great vessel distribution. 4 . They can confirm the diagnosis. Chapter 38. Hormone Replacement Therapy & Osteoporosis 1. The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing: 1 . Cardiovascular risk 2 . Risk of stroke or other thromboembolic event 3 . Breast cancer 4 . Vasomotor symptoms 2. The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is: 1 . 2 years 2 . 5 years 3 . 10 years 4 . 15 years 3. Dosage changes of conjugated equine estrogen (Premarin) are made at _ intervals. 1 . 1 to 2 week 2 . 2 to 4 week 3 . 6 to 8 week 4 . 12 week

97 ADV Pharm | TextBook | StudyGuide 4. The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy & dryness is: 1. Ability to deliver higher doses of estrogen in a non-oral form 2. The vaginal cream formula provides moisture to the vaginal area 3. Relief of symptoms without increasing cardiovascular risk 4. All of the above 5. Women with an intact uterus should be treated with both estrogen & progestin due to: 1 . Increased risk for endometrial cancer if estrogen alone is used 2 . Combination therapy provides the best relief of menopausal vasomotor symptoms 3 . Reduced risk for colon cancer with combined therapy 4 . Lower risk of developing blood clots with combined therapy 6. Ongoing monitoring for women on ERT includes: 1. Lipid levels, repeated annually if abnormal 2. Annual health history & review of risk profile 3. Annual mammogram 4. All of the above 7. Kristine would like to start HRT to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a woman considering hormone replacement would include: 1 . Explaining that HRT is totally safe if used short term 2 . Telling her to ignore media hype regarding HRT 3 . Discussing the advantages & risks of HRT 4 . Encouraging the patient to use phytoestrogens with the HRT 8. Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would you provide Angela about her risk? 1 . She is correct, black women do not have much risk of developing osteoporosis due to their dark skin.